Загрузка...
Pathologic complete response rate according to HER2 detection methods in HER2 positive breast cancer treated with neoadjuvant systemic therapy
PURPOSE: Human epidermal growth factor receptor 2 (HER2) positive breast cancers are known to have significant clinical and pathological response to neoadjuvant systemic therapy (NST). The aim of this study was to identify factors associated with pathological complete response (pCR), defined as no r...
Сохранить в:
| Опубликовано в: : | Breast Cancer Res Treat |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640097/ https://ncbi.nlm.nih.gov/pubmed/31144151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-019-05295-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|